Peter Smith
16Patents
3h-index
61Co-inventors
59Inventor score
Filing activity: Oct 26, 2012 → May 3, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8980850B2 | Administration of a NEDD8-activating enzyme inhibitor and hypomethylating agent | Human Necessities | 4 | Active |
| US9796683B2 | Tetrasubstituted alkene compounds and their use | Chemistry; Metallurgy | 4 | Active |
| US9481669B2 | Pladienolide pyridine compounds and methods of use | Chemistry; Metallurgy | 3 | Active |
| US9827246B2 | Biomarkers of response to NAE inhibitors | Emerging Cross-Sectional Technologies | 3 | Active |
| US11524009B2 | Combination comprising at least one spliceosome modulator and at least one inhibitor chosen from BCL2 inhibitors, BCL2/BCLxL inhibitors, and BCLxL inhibitors and methods of use | Human Necessities | 0 | Active |
| US11761045B2 | Splice variants associated with neomorphic SF3B1 mutants | Chemistry; Metallurgy | 0 | Active |
| US11357769B2 | Drug combinations for reducing cell viability and/or cell proliferation | Human Necessities | 0 | Active |
| US10889866B2 | Splice variants associated with neomorphic SF3B1 mutants | Chemistry; Metallurgy | 0 | Active |
| US11945807B2 | Splicing modulator antibody-drug conjugates and methods of use | Physics | 0 | Active |
| US11083722B2 | Combination therapies for the treatment of breast cancer | Human Necessities | 0 | Active |
| US10851065B2 | Tetrasubstituted alkene compounds and their use | Chemistry; Metallurgy | 0 | Active |
| US11833119B2 | Combination therapies for the treatment of hepatocellular carcinoma | Human Necessities | 0 | Active |
| US10953013B2 | Biomarkers of response to NAE inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US12172986B2 | Splicing modulator antibody-drug conjugates and methods of use | Physics | 0 | Active |
| US11352348B2 | Splicing modulator antibody-drug conjugates and methods of use | Physics | 0 | Active |
| US10745387B2 | Crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(piridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl-4-methylpiperazine-1-carboxylate and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.